Erasca, Inc. (ERAS)
16.19
-0.07
(-0.43%)
USD |
NASDAQ |
Sep 04, 16:00
16.19
0.00 (0.00%)
After-Hours: 20:00
Erasca SG&A Expense (TTM) : 41.80M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 41.80M |
| March 31, 2026 | 39.54M |
| December 31, 2025 | 38.55M |
| September 30, 2025 | 38.78M |
| June 30, 2025 | 38.32M |
| March 31, 2025 | 41.11M |
| December 31, 2024 | 41.73M |
| September 30, 2024 | 41.20M |
| June 30, 2024 | 41.04M |
| March 31, 2024 | 38.54M |
| December 31, 2023 | 37.70M |
| September 30, 2023 | 37.36M |
| June 30, 2023 | 36.69M |
| Date | Value |
|---|---|
| March 31, 2023 | 35.36M |
| December 31, 2022 | 32.99M |
| September 30, 2022 | 31.19M |
| June 30, 2022 | 29.33M |
| March 31, 2022 | 26.01M |
| December 31, 2021 | 22.62M |
| September 30, 2021 | 15.70M |
| June 30, 2021 | 10.80M |
| March 31, 2021 | 7.123M |
| December 31, 2020 | 5.052M |
| September 30, 2020 | 5.052M |
| June 30, 2020 | 3.032M |
| March 31, 2020 | 1.611M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Revolution Medicines, Inc. | 330.91M |
| Tango Therapeutics, Inc. | 56.51M |
| Arrowhead Pharmaceuticals, Inc. | 172.57M |
| Oncolytics Biotech, Inc. | 16.62M |
| Sangamo Therapeutics, Inc. | 31.64M |